Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tegafur-gimeracil-oteracil potassium
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 73 for your search:
Start Over
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 20 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: 01023010 / TOP-003, NCT00284258
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: JACCRO GC-05, NCT00639327
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG9912, C000000062, NCT00142350
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: HKIT-GC, NCT00216034
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SC101, NCT00202969
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 77
Sponsor: Pharmaceutical / Industry
Protocol IDs: ISO/5FU-10, NCT00195572
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 79
Sponsor: Other
Protocol IDs: JACCRO GC-03, NCT00287768
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Temporarily closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: HGCSG0601, IFOX study, NCT00316745
Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 01023017, NCT00498225
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000593164, TMDU-TRICC0706, TRICC0706, NCT00660894
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-03-012, NCT00677443
Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: TMOG-GC01, NCT00687843
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 10020380, NCT00770874
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: 2009-0056, NCT00869635
A Safety and Efficacy Study in Patients With Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU S-1301, TAIHO-TPU-S1301, QUINT-TPU-S1301, NCT00400179
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 74
Sponsor: Other
Protocol IDs: SOS, NCT00915382
Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU-S1303, NCT01285557
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TPU-S1101; ID02-694, NCT00072787
Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.
Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 76 to 80
Sponsor: Other
Protocol IDs: HGCSG0502, DS-Elderly, NCT00209729
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: HGCSG0405, GEMS-1, NCT00209677
Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 74
Sponsor: Other
Protocol IDs: SCC-07-01, NCT00524706
A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: 2006-01-024, NCT00531245
Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 20 to 85
Sponsor: Other
Protocol IDs: IMS-MKA0201, NCT00681252
Start Over